MPE organise a series of moderated debates which brings together
different stakeholders (advocates, physicians, industry, regulators,
etc) to discuss topics relevant to the myeloma community. The dialogues
will allow live interaction with attendees and recordings will be
published to make them widely available.
MPE dialogues: “Where are we now in myeloma and how does the future look like?”
MPE AGM 2017. Madrid. The dialogue was moderated by Alfonso Aguarón, project Manager of MPE. The following experts participated in this session:
- Dr. Albert Oriol, Hematology Department, Institut Català d’Oncologia, Spain
- Sofia Sá Cardoso, Director of Portuguese Association Against Leukaemia (APCL)
- Susanna Leto, former Patient Advocacy
Director of Novartis Oncology Europe -Jaime Espín, PhD Professor in the
Andalusian School of Public Health - Dr Beatriz Flores, Expert Medical Assessor, Medicines and Healthcare products Regulatory Agency (MHRA), UK